Targeted News Service

Study Demonstrates Drug Combination Is Well Tolerated, Safe and Effective for Patients With Aggressive Blood Cancer
June 25, 2025

BOSTON, Massachusetts, June 25 (TNSjou) -- Mass General Brigham issued the following news release:

* * *

Study Demonstrates Drug Combination Is Well Tolerated, Safe and Effective for Patients with Aggressive Blood Cancer

Using real-world data, Mass General Brigham researchers reveal how the combination of two blood cancer medications can improve outcomes for patients that do not respond well to standard therapy.

Relapsed/refractory peripheral a . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form